Prior chemo linked to cognitive decline in women

Study was carried out in newly diagnosed over 60-year-olds with non-metastatic breast cancer

Older women who have had chemotherapy for breast cancer are at increased risk of cognitive decline compared with their peers, but genetics plays an important role, a US study shows.

In the Thinking and Living with Cancer study, nearly 350 women over 60 with newly diagnosed non-metastatic breast cancer were matched one-to-one with healthy controls.